The first-ever reverse-aging drug has been injected into a human.
Catherine Falls Commercial/Getty Images
A first-of-its-kind shot that promises to reverse aging was just injected into a human body.It's a pivotal moment for longevity science, the first opportunity for researchers to prove that epigenetic reprogramming — a technique that trains aging cells to act young again — can actually improve how people age in the real world.On Tuesday, Boston-based biotech startup Life Biosciences announced that its first patient has been dosed with a cellular reprogramming injection, designed to reverse age-related diseases.Billionaires, including Jeff Bezos and Sam Altman, as well as pharmaceutical giants Eli Lilly and Merck, have been increasingly investing in this idea, which, until now, had been relegated to mouse and monkey research.If this first human trial is successful, it could usher in a new era of aging therapies aimed at making cells more youthful across the body, in a bid to improve how our DNA is expressed as we age.In this case, the injection went into one eyeball of a single person with glaucoma. The company did not share any other information about the patient. Over the next six months, scientists will be watching to see how well the technique works, while doctors keep an eye out for any safety issues."To me, it represents a potential transformational moment, not only for the company, not only for the field of aging biology, but I think potentially, and I don't say this lightly, for medicine," Life Biosciences CEO Jerry McLaughlin told Business Insider, shortly before the news was announced.
